David Stephens et al.

SEC Charges Four Defendants in Connection with Fraudulent Scheme to Sell Public Company Stock


Carl V. Dawson, et al.

Order Instituting Administrative and Cease-and-Desist Proceedings, Pursuant to 8A of the Securities Act of 1933 and Sections 15(b) and 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order


Complimentary Webinar on Requirements of Participation

Join Pathway Health and PharmScript for the complimentary webinar, “Leaders’ Overview of Updated Requirements of Participation Effective October 24, 2022.” This session will provide an overview of clarifications and updated guidance outlined in Appendix PP, including recommendations for preparation with your team. Objectives: Describe the overall changes of the updated RoP guidance effective October 24,...


Darrell Green

Order Instituting Administrative and Cease-and-Desist Proceedings, Pursuant to Sections 15(b) and 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order


Charles Rustin Holzer, Fernando Motta Moraes

SEC Charges Family Office Executives with Insider Trading


Mark J. McKinley, et al.

SEC Charges Michigan Resident with Conducting an Unregistered Securities Offering


Ari Lauer

SEC Charges California Attorney for Role in $910 Million Ponzi Scheme


Scott Lindell

SEC Charges Infinity Q's Former Senior Officer for Role in Massive Valuation Fraud


Joseph Boulos

Order Instituting Administrative Proceedings Pursuant to Section 15(b)(6) of the Securities Exchange Act of 1934, Making Findings, and Imposing Remedial Sanctions


Lisa Sanford

Order Instituting Public Administrative and Cease-And-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933, Section 4C of the Securities Exchange Act of 1934, and Rule 102(e) of the Commission's Rules of Practice, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order


Recent Post

Categories